Currently MedVector has signed NDAs with 9 Pharma/CROs and are analyzing 22 protocols. Things are getting exciting over here! Their new explainer video has been very helpful!
Organizations Involved
Not provided
Founders
Scott Stout, Dr. Dennis J. Patterson
Company Description
MedVector is an industry-first telemedicine platform that greatly accelerates clinical trials. By connecting subjects from anywhere in the world to existing clinical trial sites, MedVector has proven to exponentially increase clinical trial participation and dramatically accelerate FDA approval. Their service generates revenue for doctors and hospitals, reduces costs to clinical trial sponsors, and brings life-changing, advanced medicine to the market more quickly.